1 / 18

Countermeasure Inventory Tracking (CIT) Initiative

Countermeasure Inventory Tracking (CIT) Initiative. Jeanne Tropper, MS, MPH September 04, 2007 Division of Emergency Preparedness and Response National Center for Public Health Informatics Centers for Disease Control and Prevention. Objectives of Meeting.

alima
Download Presentation

Countermeasure Inventory Tracking (CIT) Initiative

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Countermeasure Inventory Tracking (CIT) Initiative Jeanne Tropper, MS, MPH September 04, 2007 Division of Emergency Preparedness and Response National Center for Public Health Informatics Centers for Disease Control and Prevention

  2. Objectives of Meeting • Familiarize HHS with CRA and its inventory component • Determine how CDC can capitalize on the HHS relationship with Roche and others to obtain inventory data needed for situational awareness and response planning • Explore the need for related data collection and access between HHS and CDC

  3. Countermeasure Administration Tracking (CAT) Countermeasure Inventory Tracking (CIT) CRA Information Center (CIC) What is CRA? As a program, includes the people, processes and tools to increase public health capabilities while supporting federal reporting requirements to monitor and track countermeasures pre-event, event, post-event Countermeasure & Response Administration (CRA) • Program within NCPHI/DEPR • Selected Priority Countermeasures in the Commercial Sector • Complementary to other CDC Activities: • Vaccine Tracking (NCIRD VODS) • Federal Stockpile (SNS Inventory) • Any Countermeasure, any Event • Detail Data Collection • Aggregate Reporting • Liaison with PH Partners, PHIN Help Desk, DAMC SMEs, DSLR SMEs, SNS

  4. A national program to help federal and state emergency response authorities locatecritical medical countermeasures during public health emergencies. Countermeasure and Response Administration – Inventory Tracking CRA Inventory Tracking initiative is sponsored by the Centers for Disease Control and Prevention

  5. CIT Operational Concept Data Transformation CDC DataMart SAP ManufacturerInventory and Shipment Data Filtered Data DATA FLOW EmergencyPlanning and Response DistributorInventory and Shipment Data PRODUCT FLOW Manufacturers Distributors Ordering Customers

  6. Target Countermeasures • Pandemic Influenza • Oseltamivir phosphate (Tamiflu®) • Zanamivir (Relenza®) • Bioterrorism and Infectious Diseases • Ciprofloxacin – Anthrax, Tularemia, Plague • Doxycycline – Anthrax, Tularemia, Plague • Levofloxacin (Levaquin®) – Anthrax • Streptomycin –Tularemia, Plague • Gentamicin – Tularemia, Plague, Botulism • Additional antibiotics • Selected Medical Materials

  7. Basic Data Requirements for CIT • Product Information • National Drug Code numbers and descriptions • Unit of measure/packaging • Lot number and expiration date • Inventory Data • Quantities on hand, in process/on order, commitments • Shipments • Purchase order number • Shipping information and status • Recipient identifier/type and location (zip code) No financial information will be requested!

  8. Questions about Dashboard Report • Who are the report compilers and consumers? • What is the source of Treatment Course quantities needed? • Are “Treatment Courses Due for delivery” on order or in transit?

  9. Questions about DHHS Data Sources • Who are the primary sources for Antiviral data? • Who is the POC at each data source? • Who committed the organization to be a data source? • Are data use agreements in place? • What are the characteristics of the data source communications? • Media • Standards and protocols • File formats and data elements • What are plans (if any) for expanding the number of participants?

  10. Questions about Business Operations • What contractual vehicles/purchasing provisions exist for antivirals? • How does HHS synch demand with the manufacturers?

  11. Current Status of CIT • Data Source Recruitment • Cycle 1 underway • Meeting with priority Data Source targets, leveraging CDC/HHS relationships where appropriate • 2 anti-viral manufacturers • Top 3 distributors by volume • Industry associations • Selecting targets for Cycle 2

  12. Current Status (continued) • SAP Demonstration System • Synchronized with Pan Flu exercise • Demos for requirements elicitation and refinement • Technical Assessments • Requirements for V1.0 • Data Model • Connectivity Modes, Protocols, Data Mapping

  13. CIT Demonstration(Screen Shots from Demo)

  14. How Much Antiviral Stock is in the Commercial Supply Chain? Notional Data – for Demo Only

  15. What are the Availability Characteristics of Antivirals in the Supply Chain? Notional Data – for Demo Only

  16. What Pan Flu Antivirals are Available in a Specific Area? Notional Data – for Demo Only

  17. Where have Pan Flu Antivirals Been Delivered? Notional Data – for Demo Only

  18. What is the Scope of the Initial CIT System? Notional Data – for Demo Only

More Related